Massimo Galli
- Virology top 0.1%
- HIV Research and Treatment 126
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment 95
- HIV/AIDS Research and Interventions 59
- COVID-19 Clinical Research Studies 41
- Hepatology top 0.5%
- Hepatitis C virus research 65
- Emergency Medicine top 0.2%
- HIV-related health complications and treatments 52
- Rheumatology top 0.5%
-
- Hepatitis B Virus Studies 38
- Liver Disease Diagnosis and Treatment 35
- Co-authors
- Spinello AntinoriMauro MoroniLaura MilazzoAnna Lisa RidolfoGianguglielmo ZehenderTiziano BarbuiClaudia BalottaCristina Gervasoni
- Journals
- AIDS (25 papers)AIDS Research and Human Retroviruses (18 papers)Antiviral Therapy (17 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Galli
485 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 185
- Virology 2.7k
- Infectious Diseases 5.4k
- Hepatology 1.4k
- Emergency Medicine 1.4k
- Rheumatology 1.6k
Countries citing papers authored by Massimo Galli
This map shows the geographic impact of Massimo Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Galli more than expected).
Fields of papers citing papers by Massimo Galli
This network shows the impact of papers produced by Massimo Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Galli. The network helps show where Massimo Galli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Massimo Galli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 18 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 50 | |
| 8 | 2020 | 153 | |
| 9 | 2020 | 142 | |
| 10 | 2020 | 28 | |
| 11 | 2020 | 31 | |
| 12 | 2020 | 7 | |
| 13 | 2019 | 4 | |
| 14 | 2016 | 10 | |
| 15 | 2014 | 4 | |
| 16 | 2012 | 81 | |
| 17 | Il progetto agro-urbano: una riflessione sulle prospettive di sviluppo | 2010 | 2 |
| 18 | 2009 | 68 | |
| 19 | Gestione del territorio rurale e paesaggio | 2006 | 1 |
| 20 | 2003 | 95 |
About Massimo Galli
Massimo Galli is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 500 papers that have together received 13.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (126 papers), HIV/AIDS drug development and treatment (95 papers), Hepatitis C virus research (65 papers), HIV/AIDS Research and Interventions (59 papers), HIV-related health complications and treatments (52 papers), COVID-19 Clinical Research Studies (41 papers), Hepatitis B Virus Studies (38 papers) and Liver Disease Diagnosis and Treatment (35 papers). The work is most often cited by research in Virology (2.7k citations), Infectious Diseases (5.4k citations) and Hepatology (1.4k citations). Massimo Galli has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Spinello Antinori, Mauro Moroni, Laura Milazzo, Anna Lisa Ridolfo, Gianguglielmo Zehender, Tiziano Barbui, Claudia Balotta, Cristina Gervasoni, Alessia Lai and Edouard M. Bevers. Their work appears in journals such as AIDS, AIDS Research and Human Retroviruses, Antiviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.